Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/332008
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2021-07-19T05:40:25Z-
dc.date.available2021-07-19T05:40:25Z-
dc.identifier.urihttp://hdl.handle.net/10603/332008-
dc.description.abstractIn this study we have developed and optimized nanocarrier system for colorectal delivery using natural and colon specific polymers. The 5Fluorouracil and Irinotecan hydrochloride loaded polymeric nanoparticles were formulated and characterized for its physiochemical parameters. 5 Fluorouracil is potent anticancer drug used in therapy of colorectal cancer which is associated with the several limitations. So there is a need of alternate novel delivery system to enhance the drug availability in colon. To find out the physico chemical interaction between 5 Fluorouracil and Chitosan, FT-IR analysis were carried out and found to be compatible with each other. The crystallinity of the 5 Fluorouracil loaded chitosan nanoparticles was investigated using DSC and it was found that the drug included in the nanoparticles was in amorphous form. The statistical analysis was done for in vivo pharmacokinetic parameters. In conclusion, we developed a nanoparticulate drug delivery system for 5 Fluorouracil and Irinotecan hydrochloride using natural biodegradable polymer such as chitosan by ionic gelation method which is simpler, devoid of organic solvents and high temperature. The targeting efficiency was enhanced by conjugating with hyaluronic acid and the data obtained for their particle size, zeta potential, morphology, entrapment efficiency, drug loading, nanoparticle yield, in vitro drug release, in vitro cytotoxicity and its stability were found to be satisfactory. The preparation of 5 Fluorouracil and Irinotecan hydrochloride core tablets and their evaluation such as hardness, friability, disintegration, and uniformity content are within the I.P limits. Hence it may be recommended that the formulation of 5 Fluorouracil and Irinotecan hydrochloride as a nanoparticulate drug delivery system will be a promising drug release system for the therapy of colorectal cancer. The future studies may be carried out on clinical trials for the above formulations. newline
dc.format.extent195
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleStudy of anticancer nanoparticles for colorectal cancer
dc.title.alternative
dc.creator.researcherBarish
dc.subject.keywordanticancer
dc.subject.keywordcolorectal cancer (CRC)
dc.subject.keywordnanoparticles
dc.description.note
dc.contributor.guideManavalan R
dc.publisher.placeChennai
dc.publisher.universityThe Tamil Nadu Dr. M.G.R. Medical University
dc.publisher.institutionDepartment of Pharmacy
dc.date.registered
dc.date.completed2016
dc.date.awarded
dc.format.dimensions
dc.format.accompanyingmaterialNone
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Department of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File63.25 kBAdobe PDFView/Open
02_certificate.pdf47.64 kBAdobe PDFView/Open
03_preliminary pages.pdf97.32 kBAdobe PDFView/Open
04_chapter 1.pdf190.25 kBAdobe PDFView/Open
05_chapter 2.pdf45.36 kBAdobe PDFView/Open
06_chapter 3.pdf56.71 kBAdobe PDFView/Open
07_chapter 4.pdf531.37 kBAdobe PDFView/Open
08_chapter 5.pdf37.21 kBAdobe PDFView/Open
09_chapter 6.pdf57.39 kBAdobe PDFView/Open
10_chapter 7.pdf93.11 kBAdobe PDFView/Open
11_chapter 8.pdf488.09 kBAdobe PDFView/Open
12_chapter 9.pdf2.36 MBAdobe PDFView/Open
13_bibliography.pdf91.07 kBAdobe PDFView/Open
14_publications.pdf9.36 MBAdobe PDFView/Open
80_recommendation.pdf154.04 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: